Cargando…

Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer

Muscle-invasive bladder cancer (MIBC) is an aggressive malignancy with high mortality, and heterogeneity in MIBC results in variable clinical outcomes, posing challenges for clinical management. Extracellular vesicles (EVs) derived from MIBC have been shown to promote cancer progression. EVs derived...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silvers, Christopher R., Liu, Yu-Ru, Wu, Chia-Hao, Miyamoto, Hiroshi, Messing, Edward M., Lee, Yi-Fen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029630/ https://www.ncbi.nlm.nih.gov/pubmed/26981774 http://dx.doi.org/10.18632/oncotarget.8024

Ejemplares similares

Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer
por: Silvers, Christopher R., et al.
Publicado: (2017)

Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer
por: Silvers, Christopher R., et al.
Publicado: (2021)

Molecular Landscape of Non-Muscle Invasive Bladder Cancer
por: Messing, Edward M.
Publicado: (2018)

Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond
por: Liu, Yu-Ru, et al.
Publicado: (2018)

Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity
por: Ortiz-Bonilla, Carlos J., et al.
Publicado: (2022)

Periostin modulates extracellular matrix behavior in tendons
por: Rolnick, Kevin I., et al.
Publicado: (2022)

Periostin Is Required for the Maintenance of Muscle Fibers during Muscle Regeneration
por: Ito, Naoki, et al.
Publicado: (2021)

Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Guancial, Elizabeth A., et al.
Publicado: (2016)

Bladder cancer detection by urinary extracellular vesicle mRNA analysis
por: Murakami, Taku, et al.
Publicado: (2018)

E-liquid exposure induces bladder cancer cells to release extracellular vesicles that promote non-malignant urothelial cell transformation
por: Molony, Ryan D., et al.
Publicado: (2023)

Biological Features of Extracellular Vesicles and Challenges
por: Zeng, Ye, et al.
Publicado: (2022)

Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer
por: Siriwardena, B S M S, et al.
Publicado: (2006)

Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell
por: Kudo, Akira
Publicado: (2011)

Periostin in cerebrovascular disease
por: Kawakita, Fumihiro, et al.
Publicado: (2019)

Periostin in Allergy and Inflammation
por: Sonnenberg-Riethmacher, Eva, et al.
Publicado: (2021)

Role of periostin in ECRS
por: Yu, Lei, et al.
Publicado: (2020)

Checkpoint Inhibitors for Advanced Bladder Cancer
por: Messing, Edward M.
Publicado: (2016)

Financial Toxicity of Having Bladder Cancer
por: Messing, Edward M.
Publicado: (2018)

Milk-borne small extracellular vesicles: kinetics and mechanisms of transport, distribution, and elimination
por: Ngu, Alice, et al.
Publicado: (2023)

Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair
por: Jackson-Boeters, Linda, et al.
Publicado: (2009)

Extracellular Vesicles as Potential Bladder Cancer Biomarkers: Take It or Leave It?
por: Teixeira-Marques, Ana, et al.
Publicado: (2023)

1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer
por: Hsu, Jong-Wei, et al.
Publicado: (2013)

Contribution of Extracellular Vesicles in Rebuilding Injured Muscles
por: Bittel, Daniel C., et al.
Publicado: (2019)

Muscle and Adipose Tissue Communicate with Extracellular Vesicles
por: Rome, Sophie
Publicado: (2022)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Psychological Stress and Suicide in Bladder Cancer Patients
por: Messing, Edward M.
Publicado: (2018)

Perioperative Blood Transfusions and Bladder Cancer Outcomes
por: Messing, Edward M.
Publicado: (2018)

Clinicopathological Features and Survival Analysis in Molecular Subtypes of Muscle-Invasive Bladder Cancer
por: Sanguedolce, Francesca, et al.
Publicado: (2023)

Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era
por: Zeng, Jiping, et al.
Publicado: (2023)

Periostin suppresses in vivo invasiveness via PDK1/Akt/mTOR signaling pathway in a mouse orthotopic model of bladder cancer
por: Kim, Chul Jang, et al.
Publicado: (2017)

The role of periostin in kidney diseases
por: Turczyn, Agnieszka, et al.
Publicado: (2021)

Periostin: biology and function in cancer
por: Dorafshan, Shima, et al.
Publicado: (2022)

Periostin in Osteoporosis and Cardiovascular Disease
por: Pickering, Marie-Eva, et al.
Publicado: (2023)

Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma
por: Kim, Ga-Eon, et al.
Publicado: (2017)

Identification of a novel angiogenic peptide from periostin
por: Kim, Ba Reun, et al.
Publicado: (2017)

Non-stem bladder cancer cell-derived extracellular vesicles promote cancer stem cell survival in response to chemotherapy
por: Chung, Wei-Min, et al.
Publicado: (2021)

Estrogen Receptor Alpha Prevents Bladder Cancer Development via INPP4B inhibited Akt Pathway in vitro and in vivo
por: Hsu, Iawen, et al.
Publicado: (2014)

Extracellular Vesicles as Biomarkers Carriers in Bladder Cancer: Diagnosis, Surveillance, and Treatment
por: Georgantzoglou, Natalia, et al.
Publicado: (2021)

Urinary extracellular vesicles: a rising star in bladder cancer management
por: Urabe, Fumihiko, et al.
Publicado: (2021)

Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients
por: Igami, Ko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eh3v55km34q35dk76qcebidvdj